Finance and funding: latest news

Finance and funding features

Finance and funding news from aidsmap

More news

Finance and funding news selected from other sources

  • Analysis reveals extent of drug industry funding of UK patient organisations

    The researchers call for greater transparency to ensure that industry funding is not unduly influenced by commercial objectives.

    23 May 2019 | The BMJ press release
  • The lipstick that has raised $500m for charity

    Viva Glam was a Mac counter mainstay that set it apart from other big brands. The first Viva Glam lipstick launched in 1994 at the height of the HIV/Aids epidemic, with the drag queen RuPaul as its face. Decades before cause marketing became a form of reputational currency for beauty brands, Mac was quietly donating 100 per cent of the retail price – less VAT – of Viva Glam products to HIV/Aids causes globally.

    21 May 2019 | Irish Times
  • Trump Administration Caves To Pharma On Medicare Part D 'Protected Classes' Reform

    The Trump administration has shelved a proposal that would have stymied egregious price hikes in the Medicare prescription drug program. It’s a major win for the drug industry, and a defeat for Trump’s goal of reducing drug prices.

    17 May 2019 | Forbes
  • Vienna Life Ball to raise money for HIV/Aids charities to end

    Organisers say it is hard to find sponsors for the event because of progress in tackling the virus.

    17 May 2019 | BBC News
  • England: Sexual Health Checks Fall By Almost 250,000 As Services Suffer Severe Cuts

    Sexual and reproductive health checks have fallen by 245,000 in three years, amid “swingeing” cuts to the vital services, new figures published by the Labour party show. Spending on the facilities by local authorities fell by £56 million over the past five years, according to House of Commons library data.

    14 May 2019 | Huffington Post
  • NIH Awards Will Advance Development of Vaccines for Sexually Transmitted Infections

    The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced awards to establish four Cooperative Research Centers (CRCs) focused on developing vaccines to prevent sexually transmitted infections (STIs). The grants, totaling $41.6 million over five years, will support collaborative, multidisciplinary research on the bacteria that cause syphilis, gonorrhea and chlamydia. At the end of the program, each center is expected to identify at least one candidate vaccine ready for testing in clinical trials.

    10 May 2019 | National Institute of Allergy and Infectious Diseases
  • NGOs claim victory over US funding cut to South Africa’s HIV programmes

    A plan to cut US funding to South Africa for HIV programmes is likely to be reversed – as long as the quality of services for people living with HIV is increased, say health NGOs. “The turnaround is a major victory for people living with HIV in the country, as critical resources will be restored,” eight NGOs are quoted in The Times as saying.

    02 May 2019 | Medical Brief
  • South Africa: Cutting U.S. funding will harm people with HIV most

    Arguably the biggest challenge facing South Africa’s HIV response today is how to support many more people living with HIV to start and, importantly, stay on treatment. Doing this in the context of a dysfunctional healthcare system will not be easy, but cannot be shied away from. Yet instead of receiving commitment to do what it will take to make this happen, South Africa is facing the threat of dramatic cuts in U.S. government funding that risk derailing future progress, gambling with people’s health and lives.

    25 April 2019 | Health GAP
  • HIV Medical Providers Strongly Oppose Proposed Changes To Medicare Drug Plan’s “Protected Classes”

    The proposed rule would allow plans to exclude certain drugs in those protected classes, including antiretrovirals.

    25 April 2019 | Poz
  • Tackling the high price of medicine

    Profit seems to be the only logic driving medicine prices, with some African countries paying more for medicine than European countries, and US citizens paying some of the highest medicine prices in the world. While there are global efforts to rein in pharmaceutical companies’ excessive profiteering from sickness, trying to remove the secrecy around prices is complicated.

    15 April 2019 | Daily Maverick
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.